Malignant Breast Neoplasm — Trials

Malignant Breast Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,628
Recruiting: 1,398
Ph III recruiting: 152
Growth YoY: +22.4%
Industry share: 18%
Top sponsor: Fudan University
Termination share: 25.6%
Trials / 1,000 deaths: 61.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,368)

clinicaltrialsPublishedShowing 301–350 of 1,830 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02732171	PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer	recruiting	N/A	600	Abramson Cancer Center at Penn MedicineOTHER	1	Aug 19, 2026	clinicaltrials
NCT03604315	Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF	recruiting	Phase 1	300	M.D. Anderson Cancer CenterOTHER	1	Aug 19, 2026	clinicaltrials